Literature DB >> 32801077

Mapping the diverse structural landscape of the flavivirus antibody repertoire.

Madhumati Sevvana1, Richard J Kuhn2.   

Abstract

Flaviviruses are emerging arthropod-borne RNA viruses, causing a broad spectrum of life-threatening disease symptoms such as encephalitis and hemorrhagic fever. Successful vaccines exist against yellow fever virus, Japanese encephalitis virus and tick-borne encephalitis virus. However, vaccine development against other flaviviruses like dengue virus is not straightforward. This is partly because of the high sequence conservation and immunological cross-reactivity among flavivirus envelope glycoproteins leading to antibody mediated enhancement of disease. A comprehensive analyses of the structural landscape of humoral immune response against flaviviruses is crucial for antigen design. Here, we compare the available structural data of several flavivirus antibody complexes with a major focus on Zika virus and dengue virus and discuss the mapped epitopes, the stoichiometry of antibody binding and mechanisms of neutralization.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Year:  2020        PMID: 32801077      PMCID: PMC7746604          DOI: 10.1016/j.coviro.2020.07.006

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  91 in total

1.  Conformational changes of the flavivirus E glycoprotein.

Authors:  Ying Zhang; Wei Zhang; Steven Ogata; David Clements; James H Strauss; Timothy S Baker; Richard J Kuhn; Michael G Rossmann
Journal:  Structure       Date:  2004-09       Impact factor: 5.006

2.  Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody.

Authors:  Joseph J B Cockburn; M Erika Navarro Sanchez; Nickolas Fretes; Agathe Urvoas; Isabelle Staropoli; Carlos M Kikuti; Lark L Coffey; Fernando Arenzana Seisdedos; Hugues Bedouelle; Felix A Rey
Journal:  Structure       Date:  2012-01-26       Impact factor: 5.006

3.  Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak.

Authors:  Zachary A Bornholdt; Hannah L Turner; Charles D Murin; Wen Li; Devin Sok; Colby A Souders; Ashley E Piper; Arthur Goff; Joshua D Shamblin; Suzanne E Wollen; Thomas R Sprague; Marnie L Fusco; Kathleen B J Pommert; Lisa A Cavacini; Heidi L Smith; Mark Klempner; Keith A Reimann; Eric Krauland; Tillman U Gerngross; Karl D Wittrup; Erica Ollmann Saphire; Dennis R Burton; Pamela J Glass; Andrew B Ward; Laura M Walker
Journal:  Science       Date:  2016-02-18       Impact factor: 47.728

4.  Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centres.

Authors:  Pavel Plevka; Anthony J Battisti; Jiraphan Junjhon; Dennis C Winkler; Heather A Holdaway; Poonsook Keelapang; Nopporn Sittisombut; Richard J Kuhn; Alasdair C Steven; Michael G Rossmann
Journal:  EMBO Rep       Date:  2011-05-13       Impact factor: 8.807

5.  Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

Authors:  Davide F Robbiani; Leonia Bozzacco; Jennifer R Keeffe; Ricardo Khouri; Priscilla C Olsen; Anna Gazumyan; Dennis Schaefer-Babajew; Santiago Avila-Rios; Lilian Nogueira; Roshni Patel; Stephanie A Azzopardi; Lion F K Uhl; Mohsan Saeed; Edgar E Sevilla-Reyes; Marianna Agudelo; Kai-Hui Yao; Jovana Golijanin; Harry B Gristick; Yu E Lee; Arlene Hurley; Marina Caskey; Joy Pai; Thiago Oliveira; Elsio A Wunder; Gielson Sacramento; Nivison Nery; Cibele Orge; Federico Costa; Mitermayer G Reis; Neena M Thomas; Thomas Eisenreich; Daniel M Weinberger; Antonio R P de Almeida; Anthony P West; Charles M Rice; Pamela J Bjorkman; Gustavo Reyes-Teran; Albert I Ko; Margaret R MacDonald; Michel C Nussenzweig
Journal:  Cell       Date:  2017-05-04       Impact factor: 41.582

Review 6.  The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences.

Authors:  Clarissa de Castro Ferreira; Ana Carolina Campi-Azevedo; Vanessa Peruhype-Magalhāes; Christiane Costa-Pereira; Cleandro Pires de Albuquerque; Luciana Feitosa Muniz; Talita Yokoy de Souza; Ana Cristina Vanderley Oliveira; Olindo Assis Martins-Filho; Licia Maria Henrique da Mota
Journal:  Expert Rev Vaccines       Date:  2017-11-27       Impact factor: 5.217

Review 7.  Flaviviruses and flavivirus vaccines.

Authors:  Franz X Heinz; Karin Stiasny
Journal:  Vaccine       Date:  2012-06-19       Impact factor: 3.641

8.  Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques.

Authors:  Diogo M Magnani; Thomas F Rogers; Nathan Beutler; Michael J Ricciardi; Varian K Bailey; Lucas Gonzalez-Nieto; Bryan Briney; Devin Sok; Khoa Le; Alexander Strubel; Martin J Gutman; Núria Pedreño-Lopez; Nathan D Grubaugh; Cassia G T Silveira; Helen S Maxwell; Aline Domingues; Mauricio A Martins; David E Lee; Erica E Okwuazi; Sherrie Jean; Elizabeth A Strobert; Ann Chahroudi; Guido Silvestri; Thomas H Vanderford; Esper G Kallas; Ronald C Desrosiers; Myrna C Bonaldo; Stephen S Whitehead; Dennis R Burton; David I Watkins
Journal:  Sci Transl Med       Date:  2017-10-04       Impact factor: 17.956

9.  Recognition determinants of broadly neutralizing human antibodies against dengue viruses.

Authors:  Alexander Rouvinski; Pablo Guardado-Calvo; Giovanna Barba-Spaeth; Stéphane Duquerroy; Marie-Christine Vaney; Carlos M Kikuti; M Erika Navarro Sanchez; Wanwisa Dejnirattisai; Wiyada Wongwiwat; Ahmed Haouz; Christine Girard-Blanc; Stéphane Petres; William E Shepard; Philippe Desprès; Fernando Arenzana-Seisdedos; Philippe Dussart; Juthathip Mongkolsapaya; Gavin R Screaton; Félix A Rey
Journal:  Nature       Date:  2015-01-12       Impact factor: 49.962

10.  A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface.

Authors:  Guntur Fibriansah; Joanne L Tan; Scott A Smith; Adamberage R de Alwis; Thiam-Seng Ng; Victor A Kostyuchenko; Kristie D Ibarra; Jiaqi Wang; Eva Harris; Aravinda de Silva; James E Crowe; Shee-Mei Lok
Journal:  EMBO Mol Med       Date:  2014-01-13       Impact factor: 12.137

View more
  6 in total

1.  Structure of Usutu virus SAAR-1776 displays fusion loop asymmetry.

Authors:  Baldeep Khare; Thomas Klose; Qianglin Fang; Michael G Rossmann; Richard J Kuhn
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-24       Impact factor: 11.205

2.  Structural Basis of Zika Virus Specific Neutralization in Subsequent Flavivirus Infections.

Authors:  Madhumati Sevvana; Thomas F Rogers; Andrew S Miller; Feng Long; Thomas Klose; Nathan Beutler; Yen-Chung Lai; Mara Parren; Laura M Walker; Geeta Buda; Dennis R Burton; Michael G Rossmann; Richard J Kuhn
Journal:  Viruses       Date:  2020-11-24       Impact factor: 5.048

3.  Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection.

Authors:  Amanda E Calvert; Susan L Bennett; Ann R Hunt; Rachel H Fong; Benjamin J Doranz; John T Roehrig; Carol D Blair
Journal:  Virology       Date:  2021-09-28       Impact factor: 3.616

4.  Can Modern Molecular Modeling Methods Help Find the Area of Potential Vulnerability of Flaviviruses?

Authors:  Daniil V Shanshin; Sophia S Borisevich; Alexander A Bondar; Yuri B Porozov; Elena A Rukhlova; Elena V Protopopova; Nikita D Ushkalenko; Valery B Loktev; Andrei I Chapoval; Alexander A Ilyichev; Dmitriy N Shcherbakov
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

Review 5.  Structural perspectives on HCV humoral immune evasion mechanisms.

Authors:  Madhumati Sevvana; Zhenyong Keck; Steven Kh Foung; Richard J Kuhn
Journal:  Curr Opin Virol       Date:  2021-06-03       Impact factor: 7.121

Review 6.  Pathogenesis and virulence of flavivirus infections.

Authors:  Sophie Wilhelmina van Leur; Tiaan Heunis; Deeksha Munnur; Sumana Sanyal
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.